Department of the Army August 18, 2006 – Federal Register Recent Federal Regulation Documents

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. patent number 6,399,332 issued June 4, 2002 entitled ``Bacterial Superantigen Vaccines,'' and U.S. patent number 6,713,284 issued March 30, 2004 entitled ``Bacterial Superantigen Vaccines,'' and all pending foreign patents to Integrated Biotherapeutics, Inc. with its principal place of business at Frederick Innovative Technology Center, Rosenstock Hall, Frederick, MD 21702.